COVID-19 vaccine Archives
VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit
Nov. 23, 2021—Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.
Common questions about COVID vaccine and pregnancy
Nov. 15, 2021— Recently, Vanderbilt University Medical Center’s Chief Epidemiologist, Dr. Tom Talbot, sat down to speak with his colleague Dr. Milner Staub, one of VUMC’s Adult Infectious Diseases specialists, about COVID vaccines, pregnancy and fertility. Staub, who is pregnant and has been vaccinated for COVID, answered important questions about issues and misperceptions associated with pregnancy and...
Vaccination day at Children’s Hospital
Nov. 11, 2021—Monroe Carell Jr. Children's Hospital at Vanderbilt began mass vaccination for children ages 5-11 on Monday, Nov. 8.
Boosta-Palooza
Oct. 7, 2021—VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week's Boosta-Palooza event.
Rounds: Hard conversations
Sep. 22, 2021—Difficult conversations are a hallmark of medicine. Patients and their families rely on us to share the facts about their illnesses that are sometimes hard to hear. While many clinicians begin to do this while training, our effectiveness in these conversations develops throughout a career. Telling a young mother she has an aggressive cancer or...
‘DNA’ podcast Season 2 explores COVID, science and trust in communities
Aug. 23, 2021—Listen to Episode 1, Blueprint for a Pandemic-Ready Society, and subscribe on your favorite platform. The first episode of the second season of Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA: Discoveries in Action, tackles bold questions and issues pushed to the surface by COVID-19. This season, the award-winning 10-episode series delves into...
Shared antibodies may push COVID-19 variants: VUMC study
Aug. 10, 2021—Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing white blood cells.
Digital growth, improvements, vaccinations: Leadership Assembly takeaways
Aug. 5, 2021—Vanderbilt University Medical Center completed its first full fiscal year of the COVID-19 era having achieved remarkable outcomes in digital health, growth and quality because of consistently strong performance from its workforce.
Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study
Jul. 27, 2021—A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.
Allergic reaction to first dose of an mRNA COVID-19 vaccine should not keep people from getting the second dose: study
Jul. 26, 2021—An immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine — those manufactured by Moderna and Pfizer BioNTech — should not keep people from getting the second dose, a multi-hospital analysis shows.
Update on COVID-19 for VUMC workforce: what you need to know
Jul. 19, 2021—COVID-19 is still very much part of our daily lives, and infection rates are on the increase in the community. VUMC continues to effectively manage COVID-19, and outpatient and inpatient volumes are back to pre-COVID levels.
Statement from VUMC: COVID-19 vaccination continues to be the way forward
Jul. 19, 2021—Last week, Vanderbilt University Medical Center announced that COVID-19 vaccinations for leaders will become mandatory. This was a carefully considered step forward in VUMC’s ongoing efforts to protect its patients and employees from the SARS-CoV-2 virus and its variants.
